Foal biomarker study finds limited value in predicting Rhodococcus equi pneumonia: full analysis

Foal biomarker study finds limited value in predicting Rhodococcus equi pneumonia

A new Equine Veterinary Journal study suggests that repeated measurement of circulating cytokines, cortisol, and vitamin D in foals may not help veterinarians predict which animals will develop Rhodococcus equi pneumonia, even on a farm where the disease is endemic. The prospective cohort study followed foals from birth to weaning and tested whether immune and hormonal profiles could distinguish those that stayed healthy from those that developed subclinical or clinically significant respiratory disease. In the end, the answer was mostly no. (pubmed.ncbi.nlm.nih.gov)

That result fits with the broader challenge of managing R. equi on breeding farms. The pathogen is a major cause of pneumonia in young foals, but susceptibility and severity vary considerably between animals. Researchers have long looked for earlier, less subjective ways to identify which foals are most likely to need treatment, especially because clinical signs can emerge after infection is already established. (pubmed.ncbi.nlm.nih.gov)

In this study, investigators collected blood from 200 initially healthy foals after birth and again at 1, 2, 4, 8, 12, and 20 weeks of age. Weekly health tracking continued through weaning, after which foals were categorized as healthy, subclinical, or clinical, with 30 foals from each group randomly selected for analysis. The team measured TNF-alpha, IL-4, IL-10, IL-17, interferon-gamma, total cortisol, percent free cortisol, and vitamin D metabolites using validated assays. They found strong age-associated differences across most analytes, but no consistent profile that predicted later pneumonia susceptibility or severity. (pubmed.ncbi.nlm.nih.gov)

The one signal that stood out was interferon-gamma. The authors reported disease-associated differences in IFN-gamma at 4 weeks and again at 20 weeks, and concluded that this finding deserves further study. Still, they emphasized important limitations: the causative pathogen was not definitively identified in each case, sampling intervals may have missed short-lived biomarker changes around disease onset, and circulating concentrations may not reflect what is happening in pulmonary tissue. (pubmed.ncbi.nlm.nih.gov)

That caution is reinforced by a second recent EVJ paper from overlapping investigators, which evaluated plasma C-reactive protein and IL-6 in 90 foals from birth to 20 weeks on a farm with endemic foal bronchopneumonia. That study also found clear age effects, including higher IL-6 concentrations shortly after birth and rising CRP after birth, but neither marker was associated with development of respiratory disease. The authors noted that infrequent later sampling, anti-inflammatory treatment in some febrile foals, and diagnosis based on clinical signs plus thoracic ultrasonography may all have limited the ability to detect acute disease-linked changes. (pmc.ncbi.nlm.nih.gov)

Industry reaction has been measured rather than dismissive. In its overview of the March 2026 EVJ infectious disease focus, the British Equine Veterinary Association said the cytokine, vitamin D, and steroid hormone paper provided valuable characterization of age-associated changes from birth to weaning, while also underscoring that none of the measured immune or hormonal parameters effectively predicted future respiratory disease. In other words, the negative finding still contributes useful baseline biology for clinicians and researchers working in endemic settings. (beva.org.uk)

Why it matters: For veterinary professionals, these studies are a reminder that not every plausible biomarker becomes a clinically useful screening tool. On farms managing endemic R. equi, periodic systemic blood panels may be less informative than hoped for triage or early intervention decisions. That has practical implications for cost, labor, and antimicrobial stewardship: if biomarkers cannot reliably sort high-risk from low-risk foals, veterinarians may need to keep relying on serial physical exams, thoracic imaging, and farm-specific disease surveillance protocols while the search continues for more precise predictors. (pubmed.ncbi.nlm.nih.gov)

What to watch: Expect follow-up work to focus on narrower immune signals such as IFN-gamma, more frequent sampling around the time of diagnosis, and tissue-level or mechanistic studies of foal immunity, including host-directed approaches that might eventually support prevention or more targeted treatment decisions. (pubmed.ncbi.nlm.nih.gov)